You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 5, November 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bullous Pemphigoid

Is It an Immunologic Disease?

W. Mitchell Sams, Jr., MD

Arch Dermatol. 1970;102(5):485-497.


Abstract

The demonstration of a serum antibody for the basement membrane of epithelial tissue has stimulated considerable speculation as well as solid research. Evidence for pemphigoid being an immunologic disease includes the following: (1) patients possess a serum IgG antibody for their own skin basement membrane, (2) this antibody is capable of binding complement, (3) both antibody and complement are found at the exact site of the pathologic change of pemphigoid, (4) polymorphonuclear leukocytes make up the major portion of the inflammatory infiltrate in this disease, and (5) the disease has a chronic clinical course. Evidence against pemphigoid being an immunologic disease is (1) the inability to transfer the disease passively, and (2) that disease activity is not consistently correlated with serum antibody levels.



Author Affiliations

Rochester, Minn

From the Department of Dermatology, Mayo Clinic and Mayo Foundation.


Footnotes

Accepted for publication July 13, 1970.

Read before the meeting of the American Dermatological Association, Boca Raton, Fla, March 23, 1970.

Reprint requests to Mayo Clinic, Rochester, Minn 55901.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vesiculobullous Skin Disease With Prominent Immunologic Feature
Millikan
JAMA 1987;258:2910-2915.
ABSTRACT  

Ocular Cicatricial Pemphigoid With Granular IgA and Complement Deposition
Proia et al.
Arch Ophthalmol 1985;103:1669-1672.
ABSTRACT  

Bullous Pemphigoid in a Man and His Nephew
Miyagawa et al.
Arch Dermatol 1983;119:605-606.
ABSTRACT  

Coexistence of Localized Bullous Pemphigoid, Morphea, and Subcorneal Pustulosis
Bernstein et al.
Arch Dermatol 1981;117:725-727.
ABSTRACT  

Bullous Pemphigoid: Therapy in Patients With and Without Diabetes Mellitus
Downham and Chapel
Arch Dermatol 1978;114:1639-1642.
ABSTRACT  

Bullous Pemphigoid in Children
Robison and Odom
Arch Dermatol 1978;114:899-902.
ABSTRACT  

Mixed Bullous Disease
Barranco
Arch Dermatol 1974;110:221-224.
ABSTRACT  

Circulating Antibodies in Cicatricial Pemphigoid
Dantzig
Arch Dermatol 1973;108:264-266.
ABSTRACT  

Cyclophosphamide in the Treatment of Pemphigus Vulgaris and Bullous Pemphigoid
Krain et al.
Arch Dermatol 1972;106:657-661.
ABSTRACT  

Cicatricial Pemphigoid: Immunofluorescent Studies
Bean et al.
Arch Dermatol 1972;106:195-199.
ABSTRACT  

The Enigma of Bullous Pemphigoid and Dermatitis Herpetiformis
Honeyman et al.
Arch Dermatol 1972;106:22-25.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.